Pre-market data show Apartment Investment and Management Company (NYSE:AIV) is -6.55% lower at $4.71 after reporting that it has completed separation of Apartment Income REIT Corp. It recently closed at $5.04, fluctuating in a day’s range from $4.88 to $6.48. Scotiabank has a Sector perform rating on AIV’s shares and set a $41 price target. The stock has a consensus Moderate Buy rating and a 52-week trading range of $24.53 to $55.68.
vTv Therapeutics Inc. (NASDAQ:VTVT) is trading at $2.13 down with -28.28 percent or -0.84 point in pre-market trading today following the announcement of topline results of phase 2 Elevage study of Azeliragon in patients with Mild Alzheimer’s disease and type 2 diabetes. It recently closed at $2.97, fluctuating in a day’s range from $2.90 to $3.43.
Xcel Brands Inc. (NASDAQ:XELB) shares traded over -14.39% lower in pre-market trading on Wednesday. The consensus recommendation for the company is Hold.
Shares of Aerpio Pharmaceuticals Inc. (ARPO) are -2.63% lower in pre-market trading this morning. The firm recently announced statistically significant topline results from Razuprotafib Glaucoma phase 2 trial. BTIG Research issued a Buy recommendation for Aerpio Pharmaceuticals Inc. with a target price of $4.
iQIYI Inc. (NASDAQ:IQ) was moving -7.66% lower in pre-market trading for New Street after declaring proposed offering of convertible senior notes and proposed offering of American depositary shares. Alongside 6 buy ratings, IQ scores an average top analyst price target of $25.01.
Veru Inc. (VERU)’s shares, up 239.27% this year, were -7.5% lower in pre-market trading. The firm lately declared positive Phase 2 clinical trial results for enobosarm, for the treatment of endocrine and chemotherapy resistant ER+/HER2- metastatic breast cancer. The average analyst price target is about $9.00, up about 238.04% over the past three months and 178.51% year to date.
Pre-market data show Pennsylvania Real Estate Investment Trust (NYSE:PEI) is -6.86% lower at $0.95. It last finished at $1.02, fluctuating in a day’s range from $0.99 to $1.0697. Analysts believe the stock will be worth $1.00 within the next 12 to 18 months.
Concord Medical Services Holdings Limited (NYSE:CCM) is trading at $3.55 down with -33.15 percent or -1.76 point in pre-market trading today. It recently closed at $5.31, fluctuating in a day’s range from $1.95 to $5.89.
Verastem Inc. (NASDAQ:VSTM) shares traded over -9.5% lower in pre-market trading on Wednesday after revealing the initiation of a Phase 2 registration-directed clinical trial of VS-6766, its RAF/MEK inhibitor, alone and in combination with defactinib, its FAK inhibitor, in patients with KRAS mutant non-small cell lung cancer (NSCLC). BTIG Research has a Neutral rating on the VSTM stock. The shares have a consensus Moderate Buy rating and a 52-week trading range of $1.08 to $4.67.
Shares of Galapagos NV (NASDAQ:GLPG) are -14.99% lower in pre-market trading this morning after Gilead and Galapagos declared new commercialization and development agreement for Jyseleca® (Filgotinib). Alongside 5 buy ratings, GLPG scores an average top analyst price target of $137.48.
Anchiano Therapeutics Ltd. (NASDAQ:ANCN) was moving -7.99% lower in pre-market trading for Wednesday, December 2020 after the company reporting definitive merger agreement with Chemomab Ltd. Oppenheimer a Perform recommendation for Anchiano Therapeutics Ltd.
ENDRA Life Sciences Inc. (NASDAQ:NDRA)’s shares, lower -3.98% over the week, were -16.06% lower in pre-market trading.